HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bax, cytochrome c, and caspase-8 staining in parotid cancer patients: markers of susceptibility in radiotherapy?

AbstractOBJECTIVE:
Negative bcl-2 and HLA-DR protein expression have been associated with responsiveness to adjuvant radiotherapy in surgically treated parotid cancer patients. The aim of this study was to investigate the prognostic significance of bax, cytochrome c, and caspase-8 protein expression in a group of surgically treated patients to determine whether they also suggest markers of responsiveness to adjuvant radiotherapy.
STUDY DESIGN:
Historical cohort study.
SETTING:
Otolaryngology department in a university hospital.
SUBJECTS AND METHODS:
The immunohistochemical expression of bax, cytochrome c, and caspase-8 were studied in paraffin-embedded tissue specimens originating from 27 surgically treated parotid cancer patients and nine patients with Warthin parotid tumors (control group) and correlated with the patients' clinicopathological characteristics and clinical outcome.
RESULTS:
Caspase-8 negative staining was more frequently observed in higher TNM stages and in tumors measuring more than 4 cm (P = 0.009 and P = 0.018, respectively). Caspase-8 (-)/cytochrome c (-) patients carried low-grade lesions without nodal involvement (P = 0.01 and P = 0.05, respectively). Caspase-8 (-) patients who received postoperative radiotherapy presented a significantly increased disease-free survival compared to those who did not (P = 0.04). Patients bearing bax (-) tumors who received postoperative radiotherapy presented an improved four-year disease-free survival compared to bax (-) patients who did not receive any type of adjuvant radiotherapy (P = 0.017).
CONCLUSION:
Bax, cytochrome c, and caspase-8 protein expression failed to independently predict survival in parotid cancer patients. However, patients with bax (-) or caspase-8 (-) tumors should be considered as candidates for adjuvant radiotherapy in order to achieve better local disease control.
AuthorsJohn Giotakis, Ilias P Gomatos, Leonidas Alevizos, Anastasia N Georgiou, Emmanuel Leandros, Manousos M Konstadoulakis, Leonidas Manolopoulos
JournalOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (Otolaryngol Head Neck Surg) Vol. 142 Issue 4 Pg. 605-11 (Apr 2010) ISSN: 1097-6817 [Electronic] England
PMID20304286 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2010 American Academy of Otolaryngology-Head and Neck Surgery Foundation. Published by Mosby, Inc. All rights reserved.
Chemical References
  • Biomarkers
  • bcl-2-Associated X Protein
  • Cytochromes c
  • Caspase 8
Topics
  • Adenolymphoma (chemistry)
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers (analysis)
  • Caspase 8 (analysis)
  • Cytochromes c (analysis)
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Parotid Neoplasms (chemistry, mortality, radiotherapy, surgery)
  • Radiotherapy, Adjuvant
  • Survival Rate
  • bcl-2-Associated X Protein (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: